Bundas24 Bundas24
Rezultatele cautarii
Vedeti tot
  • Conecteaza-te
    Conecteaza-te
    Inscrie-te
    Căutare
    Night Mode

Căutare

Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni

  • News Feed
  • EXPLORE
  • Pagini
  • Grupuri
  • Events
  • Blogs
  • Marketplace
  • Funding
  • Offers
  • Jobs
  • Courses
  • Forums
  • Postari
  • Blogs
  • Utilizatori
  • Pagini
  • Grupuri
  • Events
  • Khushbu Coherent a adăugat un sunet Health
    2025-05-26 10:42:21 -
    Gene Therapy in Ophthalmology Market is Driven by Innovative Treatment Technologies
    Gene therapy in ophthalmology involves the use of viral and non-viral vectors to deliver genetic material directly into ocular tissues, aiming to treat inherited retinal diseases, age-related macular degeneration (AMD), and other degenerative disorders of the eye. Key products include adeno-associated virus (AAV) vectors, lentiviral systems, and emerging CRISPR/Cas-based modalities, each...
    0 Commentarii 0 Distribuiri 182 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
  • Khushbu Coherent a adăugat un sunet Health
    2025-05-20 11:06:39 -
    Mydriasis Treatment Market is driven by rising eye disorder prevalence
    Mydriasis refers to the controlled dilation of the pupil, a critical process in advanced ophthalmic diagnostics and surgical procedures. The Mydriasis Treatment Market offers a broad portfolio of topical and injectable agents—including tropicamide, cyclopentolate, phenylephrine, and atropine—engineered to optimize pupil dilation with rapid onset and predictable duration. These...
    0 Commentarii 0 Distribuiri 214 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
  • Khushbu Coherent a adăugat un sunet Health
    2025-05-27 09:56:01 -
    Ocular Hypertension Market is driven by early diagnosis demand
      Ocular hypertension management primarily involves the use of pressure‐lowering pharmaceuticals, advanced diagnostic devices, and combination therapies designed to prevent the progression to glaucoma. Key products include topical prostaglandin analogs, beta blockers, alpha agonists, and carbonic anhydrase inhibitors, often administered via innovative sustained‐release formulations....
    0 Commentarii 0 Distribuiri 146 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
© 2025 Bundas24 Romaian
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About Termeni Confidențialitate Contacteaza-ne Director